Member Info for volcano

lets agree to disagree mate, keep safe

I agree with that , i am talking about 5:40 min

Why does normal discussion becomes ramping and deramping .
there is always people will have different views that is life .
i like the facts that dosen't make me a deramper , lol
if you keep shouting buy buy buy ,what are you then?
post facts not fantasy

He said over the summer ,not two weeks ,
by the way i bought in this morning at 31p so i not deramping it

no, it doesn't , watch it again please,

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.

but could be months away yet, Rome wasn't build in a day ,lol

count your self lucky you are in profits mate,i bet lots of people here wish they were in your position .

"Placing") through the issuance of 20,833,333 new ordinary shares ("Ordinary Shares") at a price of 18 pence per share, being the same price as the Subscription.

ADMISSION

Application will be made to the London Stock Exchange for the New Ordinary Shares, to be issued pursuant to the Fundraising, to be admitted to trading on AIM and it is expected that Admission will become effective and trading in the New Ordinary Shares will commence on or around 8.00 a.m. on 24 April 2020.

AVACTA share interactive chart (AVCT) - London Stock ...www.londonstockexchange.com › summary › company-summary-chart
FTSE ICB sector, Pharmaceuticals and Biotechnology. FTSE ICB subsector, Biotechnology. Company market cap, £m*, 36.09. Admission date, 08 Aug 2006 ...

Share price now
42.50 GBX +18.50 (77.08%)
8 Apr, 11:48 BST · Disclaimer

DegsyAlmomd
i never see any comment from you before today about AVCT, so how come you know so much about this company now,
pump and dump comes to play here
you have posted 40 messages ,wow

Hundreds of millions of tests will be needed for population screening and we will be working hard to deliver an Affimer based solution on Cytiva's platform, and potentially on the platforms of other partners with whom we are in active discussion, as soon as possible. We are aiming to have developed Affimer reagents for a COVID-19 test by the end of May that can be transferred to Cytiva and potentially to other global diagnostic manufacturers to implement in a test strip".

The new kit, which allows people to test a sputum sample at home and receive results within a few minutes, is for the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). The parties anticipate that the development of the kit will be completed within 3-4 months after which, following the receipt of CE certification, the parties expect the kits to be available for sale first in Israel and then globally.

Krakenoil works other way around as well, sell on the spike ,lol

spbhoy i don't see any deramping here mate it is a genuine news , it is out there for anyone to read and to make it what you think.

looks like OTB on the up ,you would think every is ok and we are off on a holiday ,not.

Hi Supercharger,i wish i had your optimism, sitting here and looking out the window and i can see that our street carry's on as normal,if people don't fallow government guidelines this virus could be here for a long time,scary thoughts.
It is invisible enemy you can not fight it and when you get it jungle rules apply. good luck and keep safe.

UPDATE 1-UK coronavirus testing capacity boosted by new AstraZeneca, GSK lab
Wed, 8th Apr 2020 08:37Thomson Reuters

AstraZeneca is working with rival UK pharma giant GSK
and the University of Cambridge on a joint project to
develop a new lab in Cambridge, eastern England, to boost
Britain's testing capacity.

"We believe we will start testing by mid-April and be at
scale indeed with 30,000 tests a day by early May," Soriot said.

looks like CRST is carry on as normal,
Crest Nicholson Holdings PLC
CRST
232.40 GBX
+13.60 (6.22%)

no one knows when things will be back to normal yet,
Boohoo Group PLC
BOO
238.92 GBX
+20.32 (9.30%)